Target intelligence / Profile preview

Ribosomal protein S29 pseudogene 29 (RPS29P29)

Target
RPS29P29
Molecular classification
Other (Pseudogene)
01

Overview

RPS29P29 refers to *Ribosomal protein S29 pseudogene 29*, a **pseudogene** corresponding to the functional ribosomal protein S29 (RPS29)[5]. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations or lack of necessary regulatory elements[4][5]. RPS29P29 itself does not encode a functional protein and is not associated with known biological, molecular, or therapeutic roles[5]. It is one of several processed pseudogenes scattered throughout the genome that resemble RPS29[2][5]. - RPS29P29 is not a functional gene product, not a protein, receptor, enzyme, transporter, or direct therapeutic target[4][5]. - Functional and disease-related data as well as drug interactions pertain to the real RPS29 gene, not this pseudogene. - If the intention was to refer to a druggable or disease-relevant ribosomal protein, the correct gene is RPS29 ("Ribosomal protein S29", HGNC:10419), not RPS29P29[1][2][7]. - No direct therapeutic, biomarker, or drug-related roles are associated with RPS29P29[5]. RPS29P29 is a non-functional processed pseudogene, not a protein, receptor, or therapeutic target, and cannot be classified within standard molecular target categories. If you are seeking functional, biological, or therapeutic information on ribosomal protein S29, you should reference the canonical gene RPS29, not the pseudogene RPS29P29[1][2][3][5].

Other names
Ribosomal protein S29 pseudogene 29RPS29 pseudogene 29

Beyond the preview

Go deeper on Ribosomal protein S29 pseudogene 29 (RPS29P29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S29 pseudogene 29 (RPS29P29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call